|
Press Release: Bioquell invests for future growth
Automated filling and capping systems Ten steps to preventing infection in hospitals... Award by the NHS Purchasing and Supply Agency to BIOQUELL DoH & PASA Publish report on Success of BIOQUELL System in Showcase Hospital Programme BIOQUELL assist with clean up BIOQUELL Launch new Clarus L2 HPV Generator Briefing on the outbreak of Swine Influenza Virus BIOQUELL takes top prize at the Department of Health HCAI Technology Innovation Summit BBC News Films 'New Weapons Against Hospital Bugs' at Lewisham Hospital Department of Health Press Release Robot set to tackle killer hospital bugs BIOQUELL moves to newly renovated production facility Infection Control & Hospital Epidemiology Article - Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile... BIOQUELL technology showcased in seven NHS hospitals Best foot forward for cleaner hospitals East Sussex Hospitals NHS Trust Commence Deployment of RBDS Proactive Team Gloucestershire Hospitals NHS Foundation Trust are the first UK hospital to deploy a BIOQUELL Proactive team. "Hydrogen Peroxide Vapor can control Nosocomial MRSA Outbreak" - Clinical Infectious Diseases Article Rapid Review Panel upgrades BIOQUELL technology to Level One Status Department of Health Post BIOQUELL Case Studies as "Best Practice" on website Award of Joint Material Decontamination System (US military) sub-contract Deep Cleaning Service from BIOQUELL Category III decontamination service launched |
Micro News November 2007 1. Assessing MRSA recontamination following HPV decontamination A study published in this month’s Journal of Hospital Infection investigated the efficacy and recontamination rate following hydrogen peroxide vapour (HPV) decontamination (Otter et al. 2007). HPV decontamination virtually eradicated MRSA, VRE and Gram-negative rods (GNR) that had persisted despite terminal cleaning. When a patient colonised with MRSA and GNR was re-admitted into the room, MRSA recontamination occurred to pre-cleaning levels and GNR recontamination occurred towards post-cleaning levels within one week, although the patient was not colonised or infected with the GNR species recontaminating the environment. The findings of this study combined with a similar study published earlier this year (Hardy et al. 2007) suggest that MRSA recontamination will be rapid (with a few days) if MRSA patients are re-admitted but that Gram-negative recontamination may be less rapid. Re-admitted MRSA-positive patients need to be treated in isolation for HPV decontamination to have a sustained impact. 2. MRSA, diarrhoea and environmental contamination Many clinical laboratories do not routinely screen for MRSA gastrointestinal colonisation. A study published from a hospital in New Haven, CT, USA, reports that patients with heavy gastrointestinal colonization with MRSA accompanied by diarrhoea contaminated their environment 2.5-fold more frequently than patients without MRSA gastrointestinal colonization but with MRSA colonization at other sites (58.8% of 80 surfaces vs. 23.3% of 60 surfaces, P<0.0001 using Fisher’s Exact Test) (Boyce et al. 2007). This suggests that patients with MRSA gastrointestinal colonisation and diarrhoea cause widespread environmental contamination and may require additional isolation and decontamination measures. 3. Environmental contamination in surgical settings A study from Edinburgh investigated bacterial contamination of bed-control handsets in a colorectal surgical unit, which are touched frequently by patients and staff (Brady et al. 2007). 70 handsets were sampled and 29 (41.4%) grew bacteria known to cause nosocomial infections including MRSA from 9 (12.2%) of the handsets. Such hand-touch sites in the near-patient environment are cleaned infrequently in most hospitals and the study concluded with a call for consideration of novel or more effective cleaning and decontamination methods. A similar study in the same issue of Annals of the Royal College of Surgeons in England investigated contamination of MRSA-positive patients’ case-notes in surgical settings (Hamza et al. 2007). MRSA was cultured from the case-notes from 3 (6%) of 50 MRSA-positive patients. No molecular typing was conducted to investigate whether the MRSA originated from the patient and swabbing was conducted without the use of broth enrichment. Nevertheless, the study demonstrates the capacity of case-notes to harbour MRSA, which could provide a secondary reservoir for transmission. 4. More healthcare-associated infections caused by CA-MRSA Two recent studies have once again highlighted the ability of communityassociated MRSA to, somewhat paradoxically, cause problems in healthcare settings. A study from Germany reports a large healthcare-associated outbreak of PVL-positive MRSA colonization affecting 11.3% of patients and staff in three long-term care facilities in 2004, which was reduced to 5.5% by 2005 through the introduction of control measures (Wagenlehner et al.2007). The infection control measures including increased screening and decolonization therapy for affected individuals. A study from the Birmingham, Alabama in the US, where the prevalence of CA-MRSA is high, reports that 57% of MRSA surgical site infections were caused by USA300, the predominant clone caused CA-MRSA infections in the USA (Patel et al. 2007). These studies challenge the current “definition” of CA-MRSA and we may need to consider “community-origin” or “healthcare-origin” MRSA in the future. 5. Does asymptomatic colonization with C. difficile matter? In a study from Cleveland, OH in the USA, 51% of 68 patients were found to be asymptomatically colonized with toxigenic C. difficile (Riggs et al. 2007). 59% of the environmental sites in the rooms of patients with C. difficile colonization were contaminated with C. difficile compared with 24% of sites in the rooms of patients who were not colonized. Crucially, spores on the skin of asymptomatic patients were transferred easily to the hands of researchers, suggesting that transmission from colonized patients via the hands of healthcare workers is likely. This study opens the “Pandora’s box” of whether to routinely screen patients for C. difficile colonization. With isolation facilities already at a premium, especially in the UK, the identification of widespread C. difficile colonization would place further operational strain on healthcare facilities! 6. Making a business case for infection control A useful article published this month in Infection Control and Hospital Epidemiology provides a helpful step-by-step guide to making a business case for infection control. The article covers key elements of the business case including how to manage the relationship with hospital administrators, realistic cost and outcome data ascertainment and an introduction to different economic analyses to ensure that the most appropriate analysis is selected for your business case (Perencevich et al. 2007)! 7. And finally…the writing’s on the patient? Marker pens can be used to indicate correct operative sites or mark out areas of infection. Therefore, they present a theoretic risk of cross transmission. A study from Liverpool, UK, collected 21 marker pens from the wards and sampled them by “writing” on agar (Tadiparthi et al. 2007). No pathogens were cultured but an in vitro experiment demonstrated that MRSA can survive on dried pen tips for more than 30 minutes. Therefore, the use of old or dried marker pens should be avoided! References Boyce,J.M., Havill,N.L., Otter,J.A. and Adams,N.M. (2007) Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 28, 1142-1147. Brady,R.R., Kalima,P., Damani,N.N., Wilson,R.G. and Dunlop,M.G. (2007) Bacterial contamination of hospital bed-control handsets in a surgical setting: a potential marker of contamination of the healthcare environment. Ann R Coll Surg Engl 89, 656-660. Hamza, N., Bazoua, G., Al-Shajarie, Y., Kubiak, E., James, P. and Wong, C.(2007) A prospective study of the case-notes of MRSA-positive patients: a vehicle of MRSA spread. Ann R Coll Surg Engl 89, 665-667. Hardy,K.J., Gossain,S., Henderson,N., Drugan,C., Oppenheim,B.A., Gao,F. and Hawkey,P.M. (2007) Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 66, 360-368. Otter,J.A., Cummins,M., Ahmad,F., van Tonder,C. and Drabu,Y.J. (2007) Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 67, 182-188. Patel,M., Kumar,R.A., Stamm,A.M., Hoesley,C.J., Moser,S.A. and Waites,K.B.(2007) USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol 45, 3431-3433. Perencevich,E.N., Stone,P.W., Wright,S.B., Carmeli,Y., Fisman,D.N. and Cosgrove,S.E. (2007) Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 28, 1121-1133. Riggs,M.M., Sethi,A.K., Zabarsky,T.F., Eckstein,E.C., Jump,R.L. and Donskey,C.J. (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45, 992-998. Tadiparthi,S., Shokrollahi,K., Juma,A. and Croall,J. (2007) Using marker pens on patients: a potential source of cross infection with MRSA. Ann R Coll Surg Engl 89, 661-664. Wagenlehner,F.M., Naber,K.G., Bambl,E., Raab,U., Wagenlehner,C., Kahlau,D., Holler,C., Witte,W., Weidner,W., Lehn,N., Harbarth,S. and Linde,H.J. (2007) Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. J Hosp Infect 67, 114-120. |
Quick Links
|


